Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 11—November 2023
Synopsis

Detection of Novel US Neisseria meningitidis Urethritis Clade Subtypes in Japan

On This Page
Methods
Results
Discussion
Cite This Article
Figures
Figure 1
Figure 2
Figure 3
Downloads
Article
Appendix 1
Appendix 2
RIS [TXT - 2 KB]
Article Metrics
Metric Details
Author affiliations: National Institute of Infectious Diseases, Tokyo, Japan (H. Takahashi, M. Morita, Y. Ohama, K. Shimuta, Y. Akeda, M. Ohnishi); Sapporo Medical University, Sapporo, Japan (M. Yasuda); Private Care Clinic Tokyo, Tokyo (Y. Kobori); Nagoya Urology Hospital, Aichi, Japan (M. Kojima)

Cite This Article

Abstract

Neisseria meningitidis causes invasive meningococcal diseases and has also been identified as a causative agent of sexually transmitted infections, including urethritis. Unencapsulated sequence type 11 meningococci containing the gonococcal aniA-norB locus and belonging to the United States N. meningitidis urethritis clade (US_NmUC) are causative agents of urethral infections in the United States, predominantly among men who have sex with men. We identified 2 subtypes of unencapsulated sequence type 11 meningococci in Japan that were phylogenetically close to US_NmUC, designated as the Japan N. meningitidis urethritis clade (J_NmUC). The subtypes were characterized by PCR, serologic testing, and whole-genome sequencing. Our study suggests that an ancestor of US_NmUC and J_NmUS urethritis-associated meningococci is disseminated worldwide. Global monitoring of urethritis-associated N. meningitidis isolates should be performed to further characterize microbiologic and epidemiologic characteristics of urethritis clade meningococci.

Neisseria meningitidis causes invasive meningococcal diseases (IMDs), such as meningitis and septicemia. N. meningitidis is classified into 12 defined serogroups; however, most IMDs are associated with the serogroups A, B, C, W, X, and Y (1). Serogrouping is critical for IMD control because meningococcal vaccines have serogroup-specific effects (2). Whole-genome sequencing (WGS)–based typing, such as high-resolution core genome multilocus sequence typing (MLST), is the most powerful method for analyzing meningococcal isolates. However, standard MLST, which identifies sequence types (STs) of isolates according to the unique allelic profiles of 7 housekeeping genes, is still applied to meningococcal epidemiology studies because the most invasive isolates belong to a limited number of clonal complexes (CCs). For example, ST11 and the locus variants comprising CC11 meningococci are well-known hypervirulent N. meningitidis strains that have caused many pandemics (3), including IMD outbreaks that predominately occurred among men who have sex with men (MSM) (4–9).

N. gonorrhoeae is also a human pathogen capable of infecting the urethra, cervix, rectum, and oropharynx. Most gonococcal infections manifest clinically as urethritis in men or cervicitis in women, both of which are sexually transmitted infections (STI). Meningococcus and gonococcus are generally regarded as distinct taxa that cause specific diseases; however, recent findings suggest a greater overlap than was originally reported. N. gonorrhoeae is rarely identified as a causative agent of systemic infection; N. meningitidis has been reported to cause STIs, such as urethritis. An outbreak of meningococcal urethritis predominantly among MSM was reported in multiple cities in the United States (10). Causative agents were identified as CC11 N. meningitidis isolates with several unique features and classified as US N. meningitidis urethritis clade (US_NmUC) (11–14). The capsular polysaccharide (cps) locus in US_NmUC meningococci is disrupted by insertion sequence (IS) 1301 that replaced ccsA, cssB, and cssC genes and part of the csc gene causing loss of encapsulation (12). That genetic mutation also caused the loss of wild-type lipooligosaccharide sialylation, which appeared to increase mucosal surface adherence (15). Moreover, the factor H binding protein (fHbp), which binds to human factor H and inhibits the alternative complement activation pathway in the human immune system (16), was highly expressed in US_NmUC N. meningitidis isolates and might promote evasion from immune responses in the human urogenital tract (12). The most unique feature of US_NmUC meningococci is their acquisition of the N. gonorrhoeae denitrification apparatus that comprises gonococcal alleles encoding nitrate reductase AniA and nitric oxide reductase NorB and the intergenic promoter region, which confers survival in the urogenital tract (12,17).

Most US_NmUC isolates have been recovered from patients with urethritis in the United States. However, 2 US_NmUC meningococci isolates were identified in 2019 in rectal swab samples from MSM in the United Kingdom (18), and 19 US_NmUC meningococci were isolated in Vietnam in 2019 and 2020 (19). US_NmUC meningococci have not yet been reported in other countries. We report the genomic and phenotypic features of 3 unencapsulated ST11 urethritis-associated N. meningitidis strains isolated in Japan that were phylogenetically close to US_NmUC but classified as novel urethritis meningococcus clade subtypes.

Methods

N. meningitidis Isolates

Although IMDs are legally notifiable diseases in Japan, STIs caused by N. meningitidis are not. In Japan, meningococcal isolates from patients with STIs are typically collected as part of the countrywide gonococcal surveillance program (headed by M.Y.). Urethral swab samples from male patients suspected of having urethritis and cervical swab samples from female patients suspected of having cervicitis were sent to Sapporo Medical University from ≈100 clinics across Japan. We isolated strains by selective growth on Thayer-Martin medium and analyzed those isolates by using Biotyper matrix-assisted/laser desorption time-of-flight mass spectrometry (Beckman Coulter, https://www.beckmancoulter.com) and commercially available mass spectrometry profiles to identify species. We collected >1,000 gonococcal isolates annually and isolated ≈10 N. meningitidis strains under the gonococcal surveillance program, in which no misidentification of N. meningitidis as N. gonorrhoeae has occurred. We characterized 3 N. meningitidis isolates at the National Institute of Infectious Diseases by using serologic and genetic analyses.

Typing and Antimicrobial Drug Susceptibility Tests

We performed serogrouping by using PCR (20) and slide agglutination tests with meningococcal rabbit antiserum (Remel, http://www.remel.com, or Difco/Becton Dickinson, https://www.bd.com) and a commercial latex agglutination kit (Pastorex Meningitis assay; Bio-Rad Laboratories, https://www.bio-rad.com). We conducted MLST by using the standard method (21). We performed antimicrobial drug susceptibility tests by using E-tests (bioMérieux, https://www.biomerieux.com) and Mueller-Hinton agar with 5% sheep blood (Becton Dickinson), which we interpreted according to the Clinical and Laboratory Standards Institute criteria for agar dilution, as previously described (22).

WGS, Genome Assembly, and Phylogenetic Analysis

We extracted genomic DNA by using the MagMAX DNA Multi-Sample Ultra 2.0 Kit, which we then purified by using the KingFisher Duo Prime Purification System and measured concentrations by using a Qubit dsDNA HS assay kit (all from Thermo Fisher Scientific, https://www.thermofisher.com). We prepared genomic libraries for short read sequencing by using the QIAseq FX DNA Library Kit (QIAGEN, https://www.qiagen.com) and sequenced 300-bp paired-end reads on a MiSeq instrument (Illumina, https://www.illumina.com). For long-read sequencing on a MinION sequencer (Oxford Nanopore Technologies, https://nanoporetech.com), we prepared genomic libraries by using a Rapid Barcoding Kit (Oxford Nanopore Technologies) and sequenced them by using an R9.4.1 flow cell. We basecalled raw data by using Guppy 6.5.7 (23) and removed adaptors before assembly by using Porechop 0.2.3 (https://github.com/rrwick/Porechop). We generated draft genome sequences for both long and short reads by using Unicycler version 0.5.0 in conservative mode (24) and performed annotations of complete genomes and genome assemblies by using the DDBJ Fast Annotation and Submission Tool (https://dfast.ddbj.nig.ac.jp) (25). We used draft genome assemblies for PorA and FetA typing and determining the Meningococcal Deduced Vaccine Antigen Reactivity Index through PubMLST (https://www.pubmlst.org). We performed phylogenetic analyses of N. meningitidis from urethritis patients by using 26 publicly available genomes and constructed core gene alignments by using Roary version 3.12.0 and the -s and -e–mafft options (26), which were subject to SNP-sites version 2.5.1 (27) to extract single-nucleotide variants. We constructed the phylogenetic tree by using IQ-TREE version 2.0.3 (http://www.iqtree.org) with 1,000 ultrafast bootstrap replicates and visualized the tree by using iTOL (28).

Repositories

We deposited the short reads sequence data for NIID835, NIID836, and NIID838 in the DDBJ Sequence Read Archive (https://www.ddbj.nig.ac.jp) under accession nos. DRR494404 (NIID835), DRR494405 (NIID836), and DRR494406 (NIID838) and in the PubMLST database under nos. 135430 (NIID835), 135431 (NIID836), and 135432 (NIID838). The annotated complete genome assemblies of NIID835, NIID836, and NIID838 strains are also available in the GenBank, EMBL (https://www.ebi.ac.uk), and DDBJ databases under accession nos. AP028680 (NIID835), AP028681 and AP028682 (NIID836), and AP028683 (NIID838).

Results

The 3 J_NmUC N. meningitidis strains (NIID835, NIID836, and NIID838) were isolated from 3 men with urethritis that developed 4–5 days after contact with commercial sex workers for oral sexual services (Appendix 1 Table). Although N. meningitidis strains from patients with urethritis in Japan are typically classified as ST11026, which is also isolated from healthy carriers (29), or ST23, which is also isolated from IMD patients and healthy carriers (30), we identified all 3 J_NmUC N. meningitidis strains as ST11 (Appendix 1 Table). To further characterize the 3 J_NmUC N. meningitidis isolates as urethritis clade meningococci, we performed WGS, phylogenetic, and serologic analyses.

aniA-norB Locus

Figure 1

Phylogenetic analysis of the 3.5-kb aniA-norB gene locus of Neisseria spp. isolates in study detecting novel US N. meningitidis urethritis clade subtypes in Japan. Tree was constructed by using the unweighted pair group method with arithmetic mean and 1,000 bootstrap replicates. The gonococcal aniA-norB locus was derived from N. gonorrhoeae FA1090 (GenBank accession no. NC_002946.2); all others are from N. meningitidis isolates. Scale bar indicates nucleotide substitutions per site. IMD, invasive meningococcal disease; Nm, N. meningitidis, ST, sequence type; STI, sexually transmitted infection.

Figure 1. Phylogenetic analysis of the 3.5-kb aniA-norB gene locus of Neisseria spp. isolates in study detecting novel US N. meningitidisurethritis clade subtypes in Japan. Tree...

We conducted phylogenetic analysis of the 3.5-kb aniA-norB gene sequence (Appendix 2 Figure 1) for 3 J_NmUC N. meningitidis isolates from Japan, 2 N. meningitidis US_NmUC isolates, N. gonorrhoeae FA1090 (GenBank accession no. NC_002946.2), N. meningitidis MC58 (31), and 6 N. meningitidis serogroup C isolates from IMD patients in United States that were genetically very close to US_NmUC (32) (Figure 1). Moreover, we included 3 ST23 N. meningitidis isolates (NM001, NM003, and NIID574) from Japan harboring the gonococcal aniA-norB locus (30), designated as J_NmUC-II (Figure 1). The aniA-norB locus in the 3 ST11 J_NmUC isolates was 100% identical to that in US_NmUC meningococci (12,17), indicating the aniA-norB locus in the 3 J_NmUC strains was of gonococcal origin. In the 3 ST11 J_NmUC and 3 J_NmUC-II isolates, the aniA-norB locus was located between gpxA and NMB1624 genes (Appendix 2 Figure 1), which was identical to that in US_NmUC N. meningitidis strains (12). Collectively, those results indicated that the 3 ST11 J_NmUC isolates acquired the gonococcal aniA-norB locus, similar to US_NmUC meningococci.

Serogrouping and cps Locus Analysis

Figure 2

Organization of genes within the cps locus of Neisseria meningitidis isolates in study of detection of novel US N. meningitidis urethritis clade subtypes in Japan. N. meningitidis isolates from Japan (NIID835, NIID836, NIID838) and United States (US_NmUC) were compared with N. meningitidis strain FAM18 (GenBank accession no. AM421808). Open red arrows indicate the cssA, cssB, cssC, csc, and cssE genes in region A responsible for capsule synthesis and open blue arrows the ctrD, ctrC, ctrB, and ctrA genes (in that order) in region C responsible for capsule transport. Insertion sequence IS1301 is indicated. Open reading frames identical to NMC0044 (solid red), NMC0049 (gray), NMC0068 (yellow), NMC0071 (green), NMC0073 (pink), and NMC0075 (blue) in FAM18 are shown for each isolate. Partial deletion is indicated for the csc gene (csc′). The cps locus for US_NmUC had 2 configurations created by a ≈20-kb genome inversion between 2 IS1301 sequences (designated as A and B). Gene alignments in the region between the 2 IS1301 sequences have been omitted and are indicated by the dashed line. Although ctrD, ctrC, ctrB, and ctrA genes were shown to be proximal to dnaJ (12), contigs containing the dnaJ-rfbC, rfbA, and rfbB genes and the ctrD, ctrC, ctrB, and ctrA genes (shown on the left side of A and B), as well as 2 IS1301 and pykA genes (shown on the right side of A and B), were not connected by our analysis because of the absence of US_NmUC long-read sequences. Therefore, unidentified connections of the 2 contigs are indicated by a dotted line.

Figure 2. Organization of genes within the cps locus of Neisseria meningitidis isolates in study of detection of novel US N. meningitidisurethritis clade subtypes...

Although we initially identified the 3 ST11 J_NmUC N. meningitidis strains as serogroup C meningococci (MenC) by PCR (20), the strains were agglutination negative when we tested with serogroup C–specific antiserum. To clarify this discrepancy, we characterized the cps gene locus (Figure 2). In NIID835 and NIID838 isolates, cssA, cssB, and cssC genes, and part of the csc gene (region A) were deleted and replaced with IS1301, but the ctrABCD gene cluster (region C) was also deleted. In contrast to 2 copies of IS1301 in US_NmUC isolates (12), only 1 copy of IS1301 was found in the cps locus of NIID835 and NIID838 isolates. In the NIID836 J_NmUC isolate, deletions of cssA, cssB, cssC, csc genes were identical to those in NIID835 and NIID838, but the ctrABCD gene cluster remained, containing the pylA, gltS, lipA, and lipB genes, which are typically proximal to the csc and cssE genes. Furthermore, 2 copies of the rfbC, rfbA, and rfbB gene cluster were identified in the NIID836 J_NmUC isolate; only 1 copy was found in NIID835 and NIID838 isolates. Although the cps locus in the 3 J_NmUC meningococcal strains were not identical to that in US_NmUC meningococci, the J_NmUC meningococci were genotypically nongroupable. All of the genetic features within the cps and aniA-norB loci confirmed that the 3 nongroupable ST11 J_NmUC meningococci were classified into the urethritis clade.

fHbp Locus

In US_NmUC meningococci, fHbp was speculated to be highly expressed because the fHbp promoter sequence belonged to high fHbp–expressing promoter clade I (33). In the 3 ST11 J_NmUC N. meningitidis isolates, the fHbp promoter sequence, fHbp peptide, and fHbp allele were identical to those in US_NmUC meningococci strains (Appendix 2 Figure 2), suggesting fHbp might also be highly expressed in J_NmUC meningococci (12).

Phylogenetic Analysis by Using WGS

Figure 3

Phylogenetic analysis of Neisseria meningitidis from different countries in study of detection of novel US N. meningitidis urethritis clade subtypes in Japan. Strains isolated from patients with IMD (red font) or STI (blue font), serogroup (NG or C), and country of origin are indicated. US_NmUC, J_NmUC, and J_NmUC-II N. meningitidis isolates have detailed profiles (Appendix 1 Table). We included 1 sequence type 11 N. meningitidis strain isolated in Japan from a patient with an STI (SK028) and 4 serogroup C meningococci (MenC) that were phylogenetically close to SK028 (PE5, PE6, PE7, and LNP26948) (29). Moreover, we included 7 MenC phylogenetically close to US_NmUC (IMD strains in the United States) (31), 2 sequence type 11 MenC isolated from IMD patients during 2003–2020 in Japan (NIID647 and NIID716) (28), and 6 MenC phylogenetically close to the 2 MenC from Japan (28). Scale bar indicates nucleotide substitutions per site. C, serogroup C; IMD, invasive meningococcal disease; NG, nongroupable; STI, sexually transmitted infection.

Figure 3. Phylogenetic analysis of Neisseria meningitidis from different countries in study of detection of novel US N. meningitidisurethritis clade subtypes in Japan. Strains isolated from patients with...

To gain insights into the origin of J_NmUC meningococci, we performed phylogenetic analysis by using WGS to compare 9 ST11 IMD isolates from Japan (29), 1 STI isolate (NmJP12–1) (30), and 7 IMD MenC isolates from the United States that were genetically close to US_NmUC (32) (Figure 3). ST23 J_NmUC-II, ST11 serogroup W meningococci SK001 (NmJP12–1), 8 IMD MenC, and 5 STI MenC (30) isolates were genetically separate from J_NmUC and US_NmUC meningococci; 7 US IMD MenC that were close to US_NmUC (32) were also genetically close to J_NmUC. However, J_NmUC strains were the phylogenetically closest to US_NmUC, eliminating the possibility that J_NmUC was originally derived from MenC strains in Japan.

Susceptibility to Antimicrobial Drugs

Antimicrobial resistance in N. meningitidis is considered to be acquired by transmission of genetic material from N. gonorrhoeae, such as the gonococcal aniA-norB locus (14). However, US_NmUC meningococci isolated in the United States were susceptible to the third-generation cephalosporin ceftriaxone, ciprofloxacin, and rifampin, whereas ≈75%–85% of US_NmUC meningococci were nonsusceptible (intermediate susceptibility) to penicillin G (34,35). The 3 J_NmUC meningococci were susceptible to most antimicrobial drugs tested, except the NIID836 strain had intermediate susceptibility to penicillin G, similar to US_NmUC meningococci (34,35). Those results suggest that genetic material related to antimicrobial resistance genes might not be transmitted into J_NmUC N. meningitidis isolates. Of note, the NIID835 strain was susceptible to penicillin G and ceftriaxone despite having the penA327 allele, which typically reduces susceptibility to penicillin G and third-generation cephalosporins (36).

Discussion

Meningococcus and gonococcus generally colonize distinct niches in humans causing systemic (meningococcus) and sexually transmitted (gonococcus) disease; few cases exist that identify N. meningitidis as a causative agent for STI (14). Meningococcal urethritis is symptomatically indistinguishable from gonococcal urethritis; one of the main problems in clinical and public health is that meningococcal urethritis cannot be diagnosed by the existing nucleic acid amplification test, a standard method for STI diagnosis (14,34). Urethritis clade meningococci, such as US_NmUC and J_NmUC, have been isolated only from urethritis patients (10), rectal swab samples of asymptomatic MSM (18), and 1 neonatal patient with conjunctivitis (37); virulence was considered equal to gonococci. However, urethritis clade meningococci were also speculated to colonize the upper respiratory tracts of sexual partners of persons who eventually manifested urethritis. No published studies exist regarding carriage of urethritis clade meningococci in the upper respiratory tract; thus, the public health threat of urethritis clade meningococci is unclear, and emergence of this clade should be continuously monitored.

Although deletion of the cps locus or genes within this locus, which results in loss of encapsulation, is a main features of urethritis clade meningococci (12,14), the pattern of deletion within the cps locus was different between J_NmUC and US_NmUC isolates, despite the identical junctions between the csc gene and IS1301 sequences. Because meningococcal loss of encapsulation enhances adherence to human cells (15,38–44), loss of the capsule might promote N. meningitidis–induced urethritis. However, some cases of meningococcal urethritis might be caused by encapsulated N. meningitidis isolates (30). Therefore, the relationship between loss of encapsulation by deletions within the cps locus in N. meningitidis and meningococcal urethritis should be further examined.

Acquisition of the gonococcal aniA-norB locus (12) was another main feature of urethritis clade meningococci (Figure 1). In some N. meningitidis strains, such as M-17541 (Appendix 2 Figure 1), the meningococcal aniA gene was disrupted by an insertion or missense mutation (45,46). Moreover, if the meningococcal aniA gene was intact, expression was lower than that of gonococcal aniA genes (45). However, the gonococcal aniA-norB locus was not detected in some N. meningitidis isolates from patients with meningococcal urethritis (30), suggesting that acquisition of the gonococcal aniA-norB locus was advantageous (12,13,17) but not essential to cause urethritis.

A phylogenetic analysis using WGS data supports the hypothesis that US_NmUC and J_NmUC might be derived from the same ancestor (Figure 3). US_NmUC appears to have originated during 2006–2012 in the United States (32), and the ancestral strain might have been imported into Japan during the same period. However, MenC, serogroup W, and CC11 meningococci have rarely been detected in Japan for >40 years, even in IMD patients (29,47,48). Although CC11 meningococci have never been identified as a causative agent for meningococcal urethritis in Japan (29), J_NmUC meningococci, as well as the ST11 ancestral strain, might be dormant in the urethra or pharynx of persons in Japan. Therefore, further analyses of meningococcal isolates from healthy carriers and patients with urethritis will provide insights into dissemination of the N. meningitidis urethritis clade among the human population in Japan.

In conclusion, few studies have attempted to estimate the prevalence of meningococcal infections, including the urethritis clade. J_NmUC meningococci identified in this study are new subtypes of US_NmUC, and microbiologic characteristics, such as virulence and transmissibility, remain unclear. Continuous monitoring and analyses of J_NmUC meningococci will elucidate more precise features, including transmissibility and pathogenicity. Moreover, detection of J_NmUC in Japan suggests potential dissemination of several types of urethritis clade meningococci (US_NmUC and J_NmUC) worldwide. Global monitoring of urethritis-associated N. meningitidis isolates should be required to reveal further microbiologic and epidemiologic aspects of urethritis clade meningococci and to improve laboratory diagnostic testing for urethritis.

Dr. Takahashi is the chief of the urogenital infection laboratory, Department of Bacteriology I, National Institute of Infectious Diseases, Japan. His research interests focus on meningococcal epidemiology and molecular pathogenesis as well as the gonococcal equivalents.

Top

Acknowledgments

This work was supported by a grant from the Japan Agency for Medical Research and Development (grant no. JP21fk0108605) and Ministry of Healthcare and Labour of Japan (grant no. JPMH22HA1007 to H.T.).

This publication made use of the PubMLST website (https://pubmlst.org) developed by Keith Jolley and Martin Maiden (49); the website is located at the University of Oxford. The development of that site has been funded by The Wellcome Trust and European Union.

Top

References

  1. Acevedo  R, Bai  X, Borrow  R, Caugant  DA, Carlos  J, Ceyhan  M, et al. The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations. Expert Rev Vaccines. 2019;18:15–30. DOIPubMedGoogle Scholar
  2. Taha  MK, Martinon-Torres  F, Köllges  R, Bonanni  P, Safadi  MAP, Booy  R, et al. Equity in vaccination policies to overcome social deprivation as a risk factor for invasive meningococcal disease. Expert Rev Vaccines. 2022;21:659–74. DOIPubMedGoogle Scholar
  3. Mustapha  MM, Marsh  JW, Harrison  LH. Global epidemiology of capsular group W meningococcal disease (1970-2015): Multifocal emergence and persistence of hypervirulent sequence type (ST)-11 clonal complex. Vaccine. 2016;34:1515–23. DOIPubMedGoogle Scholar
  4. Schmink  S, Watson  JT, Coulson  GB, Jones  RC, Diaz  PS, Mayer  LW, et al. Molecular epidemiology of Neisseria meningitidis isolates from an outbreak of meningococcal disease among men who have sex with men, Chicago, Illinois, 2003. J Clin Microbiol. 2007;45:3768–70. DOIPubMedGoogle Scholar
  5. Marcus  U, Vogel  U, Schubert  A, Claus  H, Baetzing-Feigenbaum  J, Hellenbrand  W, et al. A cluster of invasive meningococcal disease in young men who have sex with men in Berlin, October 2012 to May 2013. Euro Surveill. 2013;18:20523. DOIPubMedGoogle Scholar
  6. Kratz  MM, Weiss  D, Ridpath  A, Zucker  JR, Geevarughese  A, Rakeman  J, et al. Community-based outbreak of Neisseria meningitidis serogroup C infection in men who have sex with men, New York City, New York, USA, 2010–2013. Emerg Infect Dis. 2015;21:1379–86. DOIPubMedGoogle Scholar
  7. Taha  MK, Claus  H, Lappann  M, Veyrier  FJ, Otto  A, Becher  D, et al. Evolutionary events associated with an outbreak of meningococcal disease in men who have sex with men. PLoS One. 2016;11:e0154047. DOIPubMedGoogle Scholar
  8. Nanduri  S, Foo  C, Ngo  V, Jarashow  C, Civen  R, Schwartz  B, et al. Outbreak of serogroup C meningococcal disease primarily affecting men who have sex with men—Southern California, 2016. MMWR Morb Mortal Wkly Rep. 2016;65:939–40. DOIPubMedGoogle Scholar
  9. Folaranmi  TA, Kretz  CB, Kamiya  H, MacNeil  JR, Whaley  MJ, Blain  A, et al. Increased risk for meningococcal disease among men who have sex with men in the United States, 2012–2015. Clin Infect Dis. 2017;65:756–63. DOIPubMedGoogle Scholar
  10. Bazan  JA, Peterson  AS, Kirkcaldy  RD, Briere  EC, Maierhofer  C, Turner  AN, et al. Notes from the field: increase in Neisseria meningitidis–associated urethritis among men at two sentinel clinics—Columbus, Ohio, and Oakland County, Michigan, 2015. MMWR Morb Mortal Wkly Rep. 2016;65:550–2. DOIPubMedGoogle Scholar
  11. Toh  E, Gangaiah  D, Batteiger  BE, Williams  JA, Arno  JN, Tai  A, et al. Neisseria meningitidis ST11 complex isolates associated with nongonococcal urethritis, Indiana, USA, 2015–2016. Emerg Infect Dis. 2017;23:336–9. DOIPubMedGoogle Scholar
  12. Tzeng  YL, Bazan  JA, Turner  AN, Wang  X, Retchless  AC, Read  TD, et al. Emergence of a new Neisseria meningitidis clonal complex 11 lineage 11.2 clade as an effective urogenital pathogen. Proc Natl Acad Sci U S A. 2017;114:4237–42. DOIPubMedGoogle Scholar
  13. Bazan  JA, Stephens  DS, Turner  AN. Emergence of a novel urogenital-tropic Neisseria meningitidis. Curr Opin Infect Dis. 2021;34:34–9. DOIPubMedGoogle Scholar
  14. Burns  BL, Rhoads  DD. Meningococcal urethritis: old and new. J Clin Microbiol. 2022;60:e0057522. DOIPubMedGoogle Scholar
  15. Bartley  SN, Tzeng  YL, Heel  K, Lee  CW, Mowlaboccus  S, Seemann  T, et al. Attachment and invasion of Neisseria meningitidis to host cells is related to surface hydrophobicity, bacterial cell size and capsule. PLoS One. 2013;8:e55798. DOIPubMedGoogle Scholar
  16. Yee  WX, Barnes  G, Lavender  H, Tang  CM. Meningococcal factor H-binding protein: implications for disease susceptibility, virulence, and vaccines. Trends Microbiol. 2023;31:805–15. DOIPubMedGoogle Scholar
  17. Tzeng  YL, Sannigrahi  S, Berman  Z, Bourne  E, Edwards  JL, Bazan  JA, et al. Acquisition of gonococcal AniA-NorB pathway by the Neisseria meningitidis urethritis clade confers denitrifying and microaerobic respiration advantages for urogenital adaptation. Infect Immun. 2023;91:e0007923. DOIPubMedGoogle Scholar
  18. Brooks  A, Lucidarme  J, Campbell  H, Campbell  L, Fifer  H, Gray  S, et al. Detection of the United States Neisseria meningitidis urethritis clade in the United Kingdom, August and December 2019 - emergence of multiple antibiotic resistance calls for vigilance. Euro Surveill. 2020;25:2000375. DOIPubMedGoogle Scholar
  19. Nguyen  HT, Phan  TV, Tran  HP, Vu  TTP, Pham  NTU, Nguyen  TTT, et al. Outbreak of sexually transmitted nongroupable Neisseria meningitidis–associated urethritis, Vietnam. Emerg Infect Dis. 2023;29:2130–4. DOIPubMedGoogle Scholar
  20. Taha  MK. Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis. J Clin Microbiol. 2000;38:855–7. DOIPubMedGoogle Scholar
  21. Maiden  MC, Bygraves  JA, Feil  E, Morelli  G, Russell  JE, Urwin  R, et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A. 1998;95:3140–5. DOIPubMedGoogle Scholar
  22. Saito  R, Nakajima  J, Prah  I, Morita  M, Mahazu  S, Ota  Y, et al. Penicillin- and ciprofloxacin-resistant invasive Neisseria meningitidis isolates from Japan. Microbiol Spectr. 2022;10:e0062722. DOIPubMedGoogle Scholar
  23. Wick  RR, Judd  LM, Holt  KE. Performance of neural network basecalling tools for Oxford Nanopore sequencing. Genome Biol. 2019;20:129. DOIPubMedGoogle Scholar
  24. Wick  RR, Judd  LM, Gorrie  CL, Holt  KE. Unicycler: Resolving bacterial genome assemblies from short and long sequencing reads. PLOS Comput Biol. 2017;13:e1005595. DOIPubMedGoogle Scholar
  25. Tanizawa  Y, Fujisawa  T, Nakamura  Y. DFAST: a flexible prokaryotic genome annotation pipeline for faster genome publication. Bioinformatics. 2018;34:1037–9. DOIPubMedGoogle Scholar
  26. Page  AJ, Cummins  CA, Hunt  M, Wong  VK, Reuter  S, Holden  MT, et al. Roary: rapid large-scale prokaryote pan genome analysis. Bioinformatics. 2015;31:3691–3. DOIPubMedGoogle Scholar
  27. Page  AJ, Taylor  B, Delaney  AJ, Soares  J, Seemann  T, Keane  JA, et al. SNP-sites: rapid efficient extraction of SNPs from multi-FASTA alignments. Microb Genom. 2016;2:e000056. DOIPubMedGoogle Scholar
  28. Letunic  I, Bork  P. Interactive Tree Of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation. Nucleic Acids Res. 2021;49(W1):W293–6. DOIPubMedGoogle Scholar
  29. Takahashi  H, Morita  M, Kamiya  H, Fukusumi  M, Sunagawa  M, Nakamura-Miwa  H, et al. Genomic characterization of Japanese meningococcal strains isolated over a 17-year period between 2003 and 2020 in Japan. Vaccine. 2023;41:416–26. DOIPubMedGoogle Scholar
  30. Ma  KC, Unemo  M, Jeverica  S, Kirkcaldy  RD, Takahashi  H, Ohnishi  M, et al. Genomic characterization of urethritis-associated Neisseria meningitidis shows that a wide range of N. meningitidis strains can cause urethritis. J Clin Microbiol. 2017;55:3374–83. DOIPubMedGoogle Scholar
  31. Tettelin  H, Saunders  NJ, Heidelberg  J, Jeffries  AC, Nelson  KE, Eisen  JA, et al. Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science. 2000;287:1809–15. DOIPubMedGoogle Scholar
  32. Retchless  AC, Kretz  CB, Chang  HY, Bazan  JA, Abrams  AJ, Norris Turner  A, et al. Expansion of a urethritis-associated Neisseria meningitidis clade in the United States with concurrent acquisition of N. gonorrhoeae alleles. BMC Genomics. 2018;19:176. DOIPubMedGoogle Scholar
  33. Biagini  M, Spinsanti  M, De Angelis  G, Tomei  S, Ferlenghi  I, Scarselli  M, et al. Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determined. Proc Natl Acad Sci U S A. 2016;113:2714–9. DOIPubMedGoogle Scholar
  34. Sukhum  KV, Jean  S, Wallace  M, Anderson  N, Burnham  CA, Dantas  G. Genomic characterization of emerging bacterial uropathogen Neisseria meningitidis, which was misidentified as Neisseria gonorrhoeae by nucleic acid amplification testing. J Clin Microbiol. 2021;59:e01699–20. DOIPubMedGoogle Scholar
  35. Bazan  JA, Tzeng  YL, Bischof  KM, Satola  SW, Stephens  DS, Edwards  JL, et al. Antibiotic susceptibility profile for the US Neisseria meningitidis urethritis clade. Open Forum Infect Dis. 2023;10:ofac661.
  36. Willerton  L, Lucidarme  J, Walker  A, Lekshmi  A, Clark  SA, Walsh  L, et al. Antibiotic resistance among invasive Neisseria meningitidis isolates in England, Wales and Northern Ireland (2010/11 to 2018/19). PLoS One. 2021;16:e0260677. DOIPubMedGoogle Scholar
  37. Kretz  CB, Bergeron  G, Aldrich  M, Bloch  D, Del Rosso  PE, Halse  TA, et al. Neonatal conjunctivitis caused by Neisseria meningitidis US urethritis clade, New York, USA, August 2017. Emerg Infect Dis. 2019;25:972–5. DOIPubMedGoogle Scholar
  38. Virji  M, Makepeace  K, Ferguson  DJ, Achtman  M, Sarkari  J, Moxon  ER. Expression of the Opc protein correlates with invasion of epithelial and endothelial cells by Neisseria meningitidis. Mol Microbiol. 1992;6:2785–95. DOIPubMedGoogle Scholar
  39. Stephens  DS, Spellman  PA, Swartley  JS. Effect of the (alpha 2—>8)-linked polysialic acid capsule on adherence of Neisseria meningitidis to human mucosal cells. J Infect Dis. 1993;167:475–9. DOIPubMedGoogle Scholar
  40. McNeil  G, Virji  M, Moxon  ER. Interactions of Neisseria meningitidis with human monocytes. Microb Pathog. 1994;16:153–63. DOIPubMedGoogle Scholar
  41. Kolb-Mäurer  A, Unkmeir  A, Kämmerer  U, Hübner  C, Leimbach  T, Stade  A, et al. Interaction of Neisseria meningitidis with human dendritic cells. Infect Immun. 2001;69:6912–22. DOIPubMedGoogle Scholar
  42. Hill  DJ, Griffiths  NJ, Borodina  E, Virji  M. Cellular and molecular biology of Neisseria meningitidis colonization and invasive disease. Clin Sci (Lond). 2010;118:547–64. DOIPubMedGoogle Scholar
  43. Sutherland  TC, Quattroni  P, Exley  RM, Tang  CM. Transcellular passage of Neisseria meningitidis across a polarized respiratory epithelium. Infect Immun. 2010;78:3832–47. DOIPubMedGoogle Scholar
  44. Takahashi  H, Kim  KS, Watanabe  H. Differential in vitro infectious abilities of two common Japan-specific sequence-type (ST) clones of disease-associated ST-2032 and carrier-associated ST-2046 Neisseria meningitidis strains in human endothelial and epithelial cell lines. FEMS Immunol Med Microbiol. 2008;52:36–46. DOIPubMedGoogle Scholar
  45. Stefanelli  P, Colotti  G, Neri  A, Salucci  ML, Miccoli  R, Di Leandro  L, et al. Molecular characterization of nitrite reductase gene (aniA) and gene product in Neisseria meningitidis isolates: is aniA essential for meningococcal survival? IUBMB Life. 2008;60:629–36. DOIPubMedGoogle Scholar
  46. Barth  KR, Isabella  VM, Clark  VL. Biochemical and genomic analysis of the denitrification pathway within the genus Neisseria. Microbiology (Reading). 2009;155:4093–103. DOIPubMedGoogle Scholar
  47. Takahashi  H, Kuroki  T, Watanabe  Y, Tanaka  H, Inouye  H, Yamai  S, et al. Characterization of Neisseria meningitidis isolates collected from 1974 to 2003 in Japan by multilocus sequence typing. J Med Microbiol. 2004;53:657–62. DOIPubMedGoogle Scholar
  48. Fukusumi  M, Kamiya  H, Takahashi  H, Kanai  M, Hachisu  Y, Saitoh  T, et al. National surveillance for meningococcal disease in Japan, 1999-2014. Vaccine. 2016;34:4068–71. DOIPubMedGoogle Scholar
  49. Jolley  KA, Maiden  MCJ. BIGSdb: Scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics. 2010;11:595. DOIPubMedGoogle Scholar

Top

Figures

Top

Cite This Article

DOI: 10.3201/eid2911.231082

Original Publication Date: October 17, 2023

Table of Contents – Volume 29, Number 11—November 2023

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.

Top

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Hideyuki Takahashi, Department of Bacteriology I, National Institute of Infectious Diseases, Toyama 1-23-1, Shinjuku-ku, Tokyo 162-8640, Japan

Send To

10000 character(s) remaining.

Top

Page created: September 29, 2023
Page updated: October 23, 2023
Page reviewed: October 23, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external